Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60

- Foong, Yi Chao, Merlo, Daniel, Patti, Francesco, Grammond, Pierre, Amato, Maria Pia, Kalincik, Tomas, Horakova, Dana, Kubala Havrdova, Eva, Weinstock-Guttman, Bianca, Lechner Scott, Jeanette, Boz, Cavit, Sa, Maria, Gresle, Melissa, Butzkueven, H, van der Walt, A, Zhu, C, MSBASE study group,, Buzzard, Katherine, Zhong, Michael, Yeh, Wei Zhen, Jokubaitis, Vilija, Monif, Mastura, Skibina, Olga, Ozakbas, Serkan

The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-Associated disease

- Liyanage, Ganesha, Trewin, Benjamin P., Buckland, Ali, Fok, Anthony, Barnett, Michael H., Reddel, Stephen W., Marignier, Romain, El Hajj, Aseel, Monif, Mastura, van der Walt, Anneke, Lechner-Scott, Jeannette, Kermode, Allan G., Lopez, Joseph A., Kalincik, T, Broadley, SA, Dale, RC, Ramanathan, S, Brilot, F, Andersen, Jane, Tea, Fiona, Merheb, Vera, Nguyen, Kristy, Lee, Fiona X. Z., Fabis-Pedrini, Marzena J., Zou, Alicia

Disability accrual in primary and secondary progressive multiple sclerosis

- Harding-Forrester, Sam, Roos, Izanne, Horakova, Dana, Kubala Havrdova, Eva, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Grand'Maison, Francois, Onofrj, Marco, Lugaresi, Alessandra, Grammond, Pierre, Ozakbas, Serkan, Nguyen, Ai-Lan, Amato, Maria Pia, Gerlach, O, Sola, P, Ferraro, D, Buzzard, K, Skibina, O, Lechner-Scott, Jeannette, Alroughani, R, Boz, C, Van Pesch, V, Malpas, Charles B., Cartechini, E, Terzi, M, Maimone, D, Ramo-Tello, C, Yamout, B, Khoury, SJ, La Spitaleri, D, Sa, MJ, Blanco, Y, Granella, F, Diouf, Ibrahima, Slee, M, Butler, E, Sidhom, Y, Gouider, R, Bergamaschi, R, Karabudak, R, Ampapa, R, Sanchez-Menoyo, JL, Prevost, J, Castillo-Trivino, T, Moradi, Nahid, McCombe, PA, Macdonell, R, Laureys, G, Van Hijfte, L, Oh, J, Altintas, A, de Gans, K, Turkoglu, R, van der Walt, A, Butzkueven, H, Sharmin, Sifat, Vucic, S, Barnett, M, Cristiano, E, Hodgkinson, S, Iuliano, G, Kappos, L, Kuhle, J, Shaygannejad, V, Soysal, A, Weinstock-Guttman, B, Izquierdo, Guillermo, Van Wijmeersch, B, Kalincik, T, Eichau, Sara, Patti, Francesco

Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial

- Diouf, Ibrahima, Malpas, Charles B., Onofrj, Marco, Lugaresi, Alessandra, Alroughani, Raed, Prat, Alexandre, Duquette, Pierre, Terzi, Murat, Boz, Cavit, Grand'Maison, Francois, Sola, Patrizia, Ferraro, Diana, Sharmin, Sifat, Grammond, P, Yamout, B, Altintas, A, Gerlach, O, Lechner-Scott, Jeannette, Bergamaschi, R, Karabudak, R, Iuliano, G, McGuigan, C, Cartechini, E, Roos, Izanne, Hughes, S, Sa, MJ, Solaro, C, Kappos, L, Hodgkinson, S, Slee, M, Granella, F, de Gans, K, McCombe, PA, Ampapa, R, Horakova, Dana, van der Walt, A, Butzkueven, H, Sánchez-Menoyo, JL, Vucic, S, Laureys, G, Sidhom, Y, Gouider, R, Castillo-Trivino, T, Gray, O, Aguera-Morales, E, Kubala Havrdova, Eva, Al-Asmi, A, Shaw, C, Al-Harbi, TM, Csepany, T, Sempere, AP, Treviño Frenk, I, Stuart, EA, Kalincik, T, Patti, Francesco, Shaygannejad, Vahid, Ozakbas, Serkan, Eichau, Sara

Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis

- Zhu, Chao, Zhou, Zhen, Roos, Izanne, Merlo, Daniel, Kalincik, Tomas, Ozakbas, Serkan, Skibina, Olga, Kuhle, Jens, Hodgkinson, Suzanne, Boz, Cavit, Alroughani, Raed, Lechner-Scott, Jeannette, Barnett, Michael, Izquierdo, Guillermo, Prat, Alexandre, Horakova, Dana, Havrdova, Eva Kubala, Macdonell, Richard, Patti, Francesco, Khoury, Samia Joseph

Management of functional communication, swallowing, cough and related disorders: Consensus recommendations for speech and language therapy

- Baker, Janet, Barnett, Caroline, McKenzie, Kirsty, Miller, Nick, Patterson, Jo, Roth, Carole, Roy, Nelson, Short, Jennifer, Utianski, Rene, van Mersbergen, Miriam, Vertigan, Anne, Carson, Alan, Cavalli, Lesley, Stone, Jon, McWhirter, L, Dietrich, Maria, Dixon, Lorna, Duffy, Joseph R., Elias, Annie, Fraser, Diane E., Freeburn, Jennifer L., Gregory, Catherine

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis

- Kalincik, Tomas, Kubala Havrdova, Eva, Ozakbas, Serkan, Kappos, Ludwig, Kuhle, Jens, Terzi, Murat, Lechner-Scott, Jeanette, Boz, Cavit, Grand'maison, Francois, Prevost, Julie, Sola, Patrizia, Ferraro, Diana, Horakova, Dana, Granella, Franco, Trojano, M, Bergamaschi, R, Pucci, E, Turkoglu, R, McCombe, PA, Pesch, VV, Van Wijmeersch, B, Solaro, C, Ramo-Tello, C, Izquierdo, Guillermo, Slee, M, Alroughani, R, Yamout, B, Shaygannejad, V, Spitaleri, D, Sánchez-Menoyo, JL, Ampapa, R, Hodgkinson, S, Karabudak, R, Butler, E, Prat, Alexandre, Vucic, S, Jokubaitis, V, Spelman, T, Butzkueven, H, Girard, Marc, Duquette, Pierre, Grammond, Pierre, Onofrj, Marco, Lugaresi, Alessandra

Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination

- Ramanathan, Sudarshini, Mohammad, Shekeeb, Henderson, Andrew P. D., Barnett, Michael Harry, Reddel, Stephen W., Brilot, Fabienne, Dale, Russell C., Tantsis, Esther, Nguyen, Tina Kim, Merheb, Vera, Fung, Victor S. C., White, Owen Bruce, Broadley, Simon, Lechner-Scott, Jeannette, Vucic, Steve

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

- Lizak, Nathaniel, Lugaresi, Alessandra, Girard, Marc, Prat, Alexandre, Grammond, Pierre, Hupperts, Raymond, Grand'Maison, Francois, Sola, Patrizia, Pucci, Eugenio, Bergamaschi, Roberto, Oreja-Guevara, Celia, Van Pesch, Vincent, Alroughani, Raed, Lechner-Scott, Jeannette, Slee, Mark, Havrdova, Eva, Horakova, Dana, Trojano, Maria, Izquierdo, Guillermo, Duquette, Pierre

Incidence and prevalence of NMOSD in Australia and New Zealand

- Bukhari, Wajih, Prain, Kerri M., Blum, Stefan, Boggild, Mike, Boundy, Karyn, Brew, Bruce J., Brown, Matthew, Brownlee, Wallace J., Butzkueven, Helmut, Carroll, William M., Chen, Celia, Coulthard, Alan, Waters, Patrick, Dale, Russell C., Woodhall, Mark, Lechner-Scott, Jeannette, O'Gorman, Cullen M., Clarke, Laura, Silvestrini, Roger A., Bundell, Christine S., Abernethy, David, Bhuta, Sandeep

Candidate-gene analysis of white matter hyperintensities on neuroimaging

- Tran, Theresa, Cotlarciuc, Ioana, Yadav, Sunaina, Hasan, Nazeeha, Bentley, Paul, Levi, Christopher, Worrall, Bradford B., Meschia, James F., Rost, Natalia, Sharma, Pankaj

Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study

- Kister, Ilya, Spelman, Tim, Iuliano, Gerardo, Hupperts, Raymond, Pucci, Eugenio, Trojano, Maria, Butzkueven, Helmut, Alroughani, Raed, Lechner-Scott, Jeannette, Duquette, Pierre, Grand'Maison, Francois, Slee, Mark, Lugaresi, Alessandra, Barnett, Michael, Grammond, Pierre

Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis

- Tao, Chunrong, Simpson, Steve, Duquette, Pierre, Girard, Marc, Grand'Maison, Francois, Grammond, Pierre, Alroughani, Raed, Terzi, Murat, Oreja-Guevara, Celia, Sajedi, Seyed Aidin, Iuliano, Gerardo, Sola, Patrizia, van der Mei, Ingrid, Lechner-Scott, Jeannette, Van Pesch, Vincent, Pucci, Eugenio, Bergamaschi, Roberto, Barnett, Michael, Ramo, Cristina, Singhal, Bhim, Spitaleri, Daniele L. A., Slee, Mark, Verheul, Freek, Blizzard, Leigh, Fernández Bolaños, Ricardo, Amato, Maria Pia, Cristiano, Edgardo, Granella, Franco, Hodgkinson, Suzanne, Fiol, Marcela, Gray, Orla, McCombe, Pamela, Saladino, Maria Laura, Sánchez Menoyo, José Luis, Havrdova, Eva, Shuey, Neil, Vucic, Steve, Shaw, Cameron, Deri, Norma, Arruda, Walter Oleschko, Butzkueven, Helmut, Spelman, Tim, Taylor, Bruce V., Horakova, Dana, Shaygannejad, Vahid, Lugaresi, Alessandra, Izquierdo, Guillermo, Trojano, Maria

Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study

- Pan, Gongbu, Simpson, Steve, Williams, David, Lechner-Scott, Jeannette, Van Der Mei, Ingrid, Charlesworth, Jac C., Lucas, Robyn, Ponsonby, Anne-Louise, Zhou, Yuan, Taylor, Bruce V.

What causes intracerebral bleeding after thrombolysis for acute ischaemic stroke?: recent insights into mechanisms and potential biomarkers

- Karaszewski, Bartosz, Houlden, Henry, Smith, Eric E., Markus, Hugh S., Charidimou, Andreas, Levi, Christopher, Werring, David J.

CT perfusion improves diagnostic accuracy and confidence in acute ischaemic stroke

- Campbell, Bruce C. V., Weir, Louise, Desmond, Patricia M., Tu, Hans T. H., Hand, Peter J., Yan, Bernard, Donnan, Geoffrey A., Parsons, Mark W., Davis, Stephen M.

The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry

- Hughes, Stella, Spelman, Timothy, Hupperts, Raymond, Boz, Cavit, Bergamaschi, Roberto, Giuliani, Giorgio, Rio, Maria Edite, Lechner-Scott, Jeannette, Van Pesch, Vincent, Iuliano, Gerardo, Fiol, Marcela, Verheul, Freek, Trojano, Maria, Lugaresi, Alessandra, Izquierdo, Guillermo, Grand'Maison, Francois, Duquette, Pierre, Girard, Marc, Grammond, Pierre, Oreja-Guevara, Celia

Familial recurrence risks for multiple sclerosis in Australia

- O'Gorman, C., Freeman, S., Kilpatrick, T. J., Lechner-Scott, J., Moscato, P., Perreau, V. M., Scott, R. J., Stankovich, J., Stewart, G. J., Chapman, C., Marriot, M., Tanner, M., Taylor, B. V., Tubridy, N., Wiley, J., Butzkueven, H., Broadley, S. A., Bahlo, M., Booth, D. R., Brown, M. A., Foote, S. J., Griffiths, L. R.

The Audio Recorded Cognitive Screen (ARCS): a flexible hybrid cognitive test instrument

- Schofield, Peter W., Lee, Stephen J., Lewin, Terry J., Lyall, Grant, Moyle, Jonson, Attia, John, McEvoy, Mark

Comparison of Bobath based and movement science based treatment for stroke: a randomised controlled trial

- van Vliet, P. M., Lincoln, N. B., Foxall, A.